DRUG

linagliptin

4 hypotheses across 2 therapeutic domains

ALL HYPOTHESES

Repurposing candidates for linagliptin

Alzheimer 1

Mediator Outcome Score Tier Lit. status Trial
SIRT1 Alzheimer's disease 0.208 Mid reproduces known completed

Inflammatory bowel disease 3

Mediator Outcome Score Tier Lit. status Trial
DPP-4 disease activity 0.358 High partial evidence completed
DPP-4 biological treatment response 0.318 High novel signal none
DPP-4 treatment escalation 0.318 High partial evidence none

Clinical trials

200 registered trials for linagliptin

Source: ClinicalTrials.gov